UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

Journal of medicinal chemistry, 1988-12, Vol.31 (12), p.2235-2246

1988

Volltextzugriff (PDF)

Design of Potent, Orally Effective, Nonpeptidal Antagonists of the Peptide Hormone Cholecystokinin

Proceedings of the National Academy of Sciences - PNAS, 1986-07, Vol.83 (13), p.4918-4922

1986

Volltextzugriff (PDF)

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Journal of medicinal chemistry, 1989-01, Vol.32 (1), p.13-16

1989

Volltextzugriff (PDF)

Development of 1,4-benzodiazepine cholecystokinin type B antagonists

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4276-4292

1993

Volltextzugriff (PDF)

Orally active, nonpeptide oxytocin antagonists

Journal of medicinal chemistry, 1992-10, Vol.35 (21), p.3919-3927

1992

Volltextzugriff (PDF)

Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide

Journal of medicinal chemistry, 1990-09, Vol.33 (9), p.2321-2323

1990

Volltextzugriff (PDF)

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists

Journal of medicinal chemistry, 1987-07, Vol.30 (7), p.1229-1239

1987

Volltextzugriff (PDF)

Tetrabutylammonium Salt Induced Denitration of Nitropyridines: Synthesis of Fluoro-, Hydroxy-, and Methoxypyridines

Organic letters, 2005-02, Vol.7 (4), p.577-579

2005

Volltextzugriff (PDF)

Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists

Bioorganic & medicinal chemistry letters, 2001-07, Vol.11 (14), p.1959-1962

2001

Volltextzugriff (PDF)

Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications

Journal of medicinal chemistry, 1990-07, Vol.33 (7), p.1843-1845

1990

Volltextzugriff (PDF)

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency

Journal of medicinal chemistry, 1988-10, Vol.31 (10), p.1918-1923

1988

Volltextzugriff (PDF)

Cholecystokinin-A receptor ligands based on the .kappa.-opioid agonist tifluadom

Journal of medicinal chemistry, 1990-01, Vol.33 (1), p.450-455

1990

Volltextzugriff (PDF)

Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity

Bioorganic & medicinal chemistry letters, 1998-09, Vol.8 (18), p.2495-2500

1998

Volltextzugriff (PDF)

Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines

Journal of medicinal chemistry, 1988-01, Vol.31 (1), p.264-268

1988

Volltextzugriff (PDF)

Phenylacetamides as selective alpha-1A adrenergic receptor antagonists

Bioorganic & medicinal chemistry letters, 2000-08, Vol.10 (15), p.1621-1624

2000

Volltextzugriff (PDF)

Cholecystokinin antagonists. Synthesis of asperlicin analogs with improved potency and water solubility

Journal of medicinal chemistry, 1986-10, Vol.29 (10), p.1941-1945

1986

Volltextzugriff (PDF)

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines

Journal of medicinal chemistry, 1988-01, Vol.31 (1), p.176-181

1988

Volltextzugriff (PDF)

Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility

Journal of medicinal chemistry, 1994-03, Vol.37 (6), p.722-724

1994

Volltextzugriff (PDF)

Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist

Journal of the American Chemical Society, 2003-06, Vol.125 (25), p.7516-7517

2003

Volltextzugriff (PDF)

Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini

Journal of medicinal chemistry, 1987-10, Vol.30 (10), p.1853-1857

1987

Volltextzugriff (PDF)

Discovery of a Potent, Non-peptide Bradykinin B 1 Receptor Antagonist

Journal of the American Chemical Society, 2003-06, Vol.125 (25), p.7516-7517

2003

Volltextzugriff (PDF)

Reversal of diastereoselection in the addition of Grignard reagents to chiral 2-pyridyl tert-butyl (Ellman) sulfinimines

Tetrahedron letters, 2004-08, Vol.45 (35), p.6641-6643

2004

Volltextzugriff (PDF)

A uniquely potent renin inhibitor and its unanticipated plasma binding component

Journal of medicinal chemistry, 1985-12, Vol.28 (12), p.1755-1756

1985

Volltextzugriff (PDF)

α-Hydroxy amides as a novel class of bradykinin B1 selective antagonists

Bioorganic & medicinal chemistry letters, 2008-01, Vol.18 (2), p.716-720

2008

Volltextzugriff (PDF)

A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity

Bioorganic & medicinal chemistry letters, 2008-01, Vol.18 (2), p.682-687

2008

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Chemistry
(34)
Animals
(31)
Life Sciences & Biomedicine
(28)
Pharmacology & Pharmacy
(26)
Chemistry, Medicinal
(23)
Physical Sciences
(23)
Structure-Activity Relationship
(23)
Rats
(22)
Chemistry, Organic
(20)
Exact Sciences And Technology
(20)
Organic Chemistry
(20)
Preparations And Properties
(20)
Biological And Medical Sciences
(15)
Heterocyclic Compounds
(15)
Medical Sciences
(14)
Pharmacology. Drug Treatments
(14)
Humans
(13)
Benzodiazepines - Chemical Synthesis
(11)
Benzodiazepines - Pharmacology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

Design of Potent, Orally Effective, Nonpeptidal Antagonists of the Peptide Hormone Cholecystokinin

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Development of 1,4-benzodiazepine cholecystokinin type B antagonists

Orally active, nonpeptide oxytocin antagonists

Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists

Tetrabutylammonium Salt Induced Denitration of Nitropyridines: Synthesis of Fluoro-, Hydroxy-, and Methoxypyridines

Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists

Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency

Cholecystokinin-A receptor ligands based on the .kappa.-opioid agonist tifluadom

Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity

Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines

Phenylacetamides as selective alpha-1A adrenergic receptor antagonists

Cholecystokinin antagonists. Synthesis of asperlicin analogs with improved potency and water solubility

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines

Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility

Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist

Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini

Discovery of a Potent, Non-peptide Bradykinin B 1 Receptor Antagonist

Reversal of diastereoselection in the addition of Grignard reagents to chiral 2-pyridyl tert-butyl (Ellman) sulfinimines

A uniquely potent renin inhibitor and its unanticipated plasma binding component

α-Hydroxy amides as a novel class of bradykinin B1 selective antagonists

A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity

Suchergebnisse filtern